Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size
American Journal of Obstetrics and Gynecology · 2024-06 · 230 (6) · 663.e1-663.e13
DOI: 10.1016/j.ajog.2024.02.012 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift American Journal of Obstetrics and Gynecology, 2024-06. Verfasst von Kirsten A Jorgensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: kaj…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Fertility Preservation, Hysterectomy, Life Expectancy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Cervical cancer incidence among premenopausal women is rising, and fertility-sparing surgery serves as an important option for this young population. There is a lack of evidence on what tumor size cutoff should be used to define candidacy for fertility-sparing surgery. OBJECTIVE: We sought to describe how the association between fertility-sparing surgery (compared with standard surgery) and life expectancy varies by tumor size among patients with cervical cancers measuring ≤4 cm in largest diameter. Our secondary objective was to quantify the probability of undergoing adjuvant radiotherapy among patients who underwent fertility-sparing surgery as a function of tumor size. STUDY DESIGN: We identified patients in the National Cancer Database aged ≤45 years, diagnosed with stage I cervical cancer with tumors ≤4 cm between 2006 and 2018, who received no preoperative radiation or chemotherapy, and who underwent either fertility-sparing surgery (cone or trachelectomy, either simple or radical) or standard surgery (simple or radical hysterectomy) as their primary treatment. Propensity-score matching was performed to compare patients who underwent fertility-sparing surgery with those who underwent standard surgery. A flexible parametric model was employed to quantify the difference in life expectancy within 5 years of diagnosis (restricted mean survival time) based on tumor size among patients who underwent fertility-sparing and those who underwent standard surgery. In addition, among those who underwent fertility-sparing surgery, a logistic regression model was used to explore the relationship between tumor size and the probability of receiving adjuvant radiation. RESULTS: A total of 11,946 patients met the inclusion criteria of whom 904 (7.6%) underwent fertility-sparing surgery. After propensity-score matching, 897 patients who underwent fertility-sparing surgery were matched 1:1 with those who underwent standard surgery. Although the 5-year life expectancy was similar among patients who had fertility sparing surgery and those who had standard surgery regardless of tumor sizes, the estimates of life-expectancy differences associated with fertility-sparing surgery were more precise among patients with smaller tumors (1-cm tumor: restricted mean survival time difference, -0.10 months; 95% confidence interval, -0.67 to 0.47) than among those with larger tumors (4-cm tumor: restricted mean survival time difference, -0.11 months; 95% confidence interval, -3.79 to 3.57). The probability of receiving adjuvant radiation increased with tumor size, ranging from 5.6% (95% confidence interval, 3.9-7.9) for a 1-cm tumor to 37% (95% confidence interval, 24.3-51.8) for a 4-cm tumor. CONCLUSION: Within 5 years of diagnosis, young patients with stage I cancers measuring ≤4 cm had similar survival outcomes after either fertility-sparing surgery or standard surgery. However, because few patients with tumors >2 cm underwent fertility-sparing surgery, a clinically important survival difference could not be excluded in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: kajorgensen@mdanderson.org.
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Clínica de Oncología Astorga, Medellín, Colombia; Instituto Nacional de Cancerología, Bogotá, Colombia.
- Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, TX.
- Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Jorgensen, K. A., Agusti, N., Wu, C. F., Kanbergs, A., Pareja, R., Ramirez, P. T., Rauh-Hain, J. A., & Melamed, A. (2024). Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size. American Journal of Obstetrics and Gynecology, 230(6), 663.e1-663.e13. https://doi.org/10.1016/j.ajog.2024.02.012
Vancouver
Jorgensen KA, Agusti N, Wu CF, Kanbergs A, Pareja R, Ramirez PT, et al. Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size. American Journal of Obstetrics and Gynecology. 2024;230(6):663.e1-663.e13. doi:10.1016/j.ajog.2024.02.012
BibTeX
@article{Jorgensen2024,
author = {Jorgensen, Kirsten A and Agusti, Nuria and Wu, Chi-Fang and Kanbergs, Alexa and Pareja, Rene and Ramirez, Pedro T and Rauh-Hain, Jose Alejandro and Melamed, Alexander},
title = {Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size},
journal = {American Journal of Obstetrics and Gynecology},
year = {2024},
volume = {230},
number = {6},
pages = {663.e1--663.e13},
doi = {10.1016/j.ajog.2024.02.012}
}
EUVIMED